Pathlight MRD Finding the Right Patients Faster

• SAGA Diagnostics has commercialized Pathlight MRD in early breast cancer and CRC
• We continue to expand Pathlight's footprint across the patient journey but into new indications
• We are further expanding our reach by offering Pathlight MRD for clinical trial referrals, enrollment and global deployment

Speakers:

Mark Landers

Senior Vice President, Biopharma

SAGA Diagnostics